A recent study highlights the crucial role of CCT2 in neurodegenerative diseases, particularly exploring its significance in Alzheimer’s disease (AD) via multi-omics analysis (Ma et al., 2023). This evidence concerns the gene CCT2 and early-onset autosomal dominant Alzheimer disease.